Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 4, July, p. 621–625

doi: 10.17219/acem/62829

PubMed ID: 28691407

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Oxidative stress, hepcidin and nesfatin-I status in childhood iron and vitamin B12 deficiency anemias

Tünay K. Aşkar1,A,B,C,D, Olga Büyükleblebici2,B,D, Adnan Adil Hismioğulları3,C,E,F, Zeynep Hünkerler4,B

1 Department of Biochemistry, Health Sciences Faculty, Çankırı Karotekin University, Turkey

2 Department of Biochemistry, Veterinary Faculty, Aksaray University, Turkey

3 Department of Medical Biochemistry, Faculty of Medicine, Balıkesir University, Turkey

4 Department of Biochemistry, Çankırı Government Hospital, Turkey

Abstract

Background. Anemia is a disease that is long and often repetitive and can result in a great burden to the national economy. The most frequent nutritional deficiency anemias in children are related with iron and vitamin B12 deficiencies.
Objectives. The aim of this study was to determine the oxidative stress, hepcidin, and nesfatin-I levels in childhood iron and vitamin B12 deficiency anemias.
Material and Methods. The study had 3 groups of 15 children, iron anemia deficiency group, vitamin B12 deficiency group and a control group.
Results. The TBARS and nesfatin-I levels were significantly higher in the iron and vitamin B12 deficiency groups and the total antioxidant levels were significantly lower when compared to the control group. In contrast, the plasma hepcidin levels were significantly lower in the iron deficiency group (p < 0.01) when compared to the control group; however, no significant differences were observed in the vitamin B12 deficiency group. Plasma homocysteine levels were significantly higher in the vitamin B12 deficiency group when compared to the control group (p < 0.001), but no differences were determined between the iron deficiency and control groups.
Conclusion. Our results showed that there are high levels of oxidative stress in childhood iron and vitamin B12 deficiency anemias, and we propose that plasma hepcidin and homocycteine levels may be useful in the differential diagnosis of childhood nutritional deficiency anemias. Nesfatin-1 hormone levels were identified for the first time in childhood iron deficiency and vitamin B12 deficiency anemias within this study and this hormone may also be useful in the differential diagnosis of anemias.

Key words

oxidative stress, hepcidin, nesfatin-I, childhood anemia

References (24)

  1. Dallman PR. Progress in the prevention of iron deficiency in infants. Acta Pediatr. 1990;365:2837.
  2. Buratti P, Gammella E, Rybinska I, Cairo G, Recalcati S. Recent advances in iron metabolism: Relevance for health, exercise, and performance. Med Sci Sports Exerc. 2014;9. doi: 10.1249/MSS.0000000000000593.
  3. Brugnara C. Iron deficiency and erythropoiesis. New diagnostic approaches. Clin Chemistry. 2003;4:1573–1578.
  4. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002;4:1066–1076.
  5. Bjørke-Monsen AL, Ueland PM. Cobalamin status in children. J Inherit Metab Dis. 2011;34(1):111–119.
  6. Altay C, Cetin M. Vitamin B12 absorption test and oral treatment in 14 children with selective vitamin B12 malabsorption. Pediatr Hematol Oncol. 1999;16(2):159–163.
  7. Ganz T. Hepcidin: A regulator of intestinal iron absorption and iron recycling by macrophages. Best Practice & Research Clinical Haematology. 2005;18(2):171–182.
  8. Rossi E. Hepcidin: The iron regulatory hormone. Clin Biochem Rev. 2005;26(3):47-49.
  9. Ganz T. Hepcidin: A key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102(3):783–788.
  10. Stengel A, Mori M, Taché Y. The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors. Obes Rev. 2013;14(11):859–870.
  11. Inal M, Akyüz F, Turgut A, Getsfrid WM. Effect of aerobic andaAnaerobic metabolism on free radical generation swimmers. Med Sci Sports Exerc. 2001;33:564–567.
  12. Özkan A, Fışkın K. Serbest oksijen radikalleri ve Karsinogenez ve antioksidan enzimler. International Journal of Hematology and Oncology. 2004;14(1):52–60.
  13. Gutteridge JM. Biological origin of free radicals, and mechanisms of antioxidant protection. Chem Biol Interact. 1994;91(2–3):133–140.
  14. Domellöf M. Iron requirements, absorption and metabolism in infancy and childhood. Curr Opin Clin Nutr Metab Care. 2007;10(3):329–335.
  15. Mccord JM. Human disease, free radicals and the oxidant/antioxidant balance. Clin Biochem. 1993;26:351–357.
  16. Kurtoglu E, Ugur A, Baltaci AK, Undar L. Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia. Biol Trace Elem Res. 2003;96:117–123.
  17. Cheng ML, Ho HY, Tseng HC, Lee CH, Shih LY, Chiu DT. Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of alpha-thalassaemia. Br J Haematol. 2005;128:119–127.
  18. Acharya J, Punchard NA, Taylor JA, Thompson RP, Pearson TC. Red cell lipid peroxidation and antioxidant enzymes in iron deficiency. Eur J Haematol. 1991;47:287–291.
  19. Al-Maskari MY, Waly MI, Ali A, Al-Shuaibi YS, Ouhtit A. Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes. Nutrition. 2012;28:23–26.
  20. Diaz-Arrastia, R. Homocycteine and neurologic disease. Arch Neurol. 2000;7:1422–1428.
  21. Savage DG, Lindenbaum J, Stabler SP. Sensitivity of serum methylmalonic acid and total homocysteine derterminations for diagnosing cobalamin and folate deficiencies. Am J Med. 1994;96:239–246.
  22. Anderson GJ, Darshan D, Wilkins SJ, Frazer DM. Regulation of systemic iron homeostasis: How the body responds to changes in iron demand. Biometals. 2007;20:665–674.
  23. Ulukol B, Orhon FS, Hanoluk A, Akar N. Serum pro-hepcidin levels in infants with iron deficiency anaemia. Int Jnl Lab Hem. 2008;30:546–547.
  24. Abacı A, Catlı G, Anık A, Kume T, Bober E. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diabetes. 2013;14:189–195.